Anlotinib combined with temozolomide for brain metastases in small cell lung cancer with early recurrence after whole-brain radiotherapy: a case report. [PDF]
Jiang B +5 more
europepmc +1 more source
Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study. [PDF]
Cives M +21 more
europepmc +1 more source
Temozolomide in pediatric low-grade glioma
Temozolomide in pediatric low-grade ...
LT Coleman (15875966) +4 more
core
ABSTRACT Background and Aims Metabolic reprogramming is a hallmark of brain tumors, extending beyond the classical Warburg effect. While glycolysis has been extensively studied, gliomas and pediatric high‐grade brain cancers demonstrate remarkable metabolic plasticity.
Iffat Islam Mayesha +5 more
wiley +1 more source
Gunstig resultaat van temozolomide bij een recidiefvan een hooggradig glioom
OBJECTIVE: To describe the results of the treatment of recurrent glioma with temozolomide. DESIGN: Retrospective. METHOD: This study evaluated 77 patients with a recurrent high-grade glioma who from August 1997-December 2003 were treated with ...
van Heuvel, I +6 more
core
Final Subcortical Motor Mapping Threshold and Overall Survival After Motor-Eloquent Glioblastoma Resection: Exploratory Analysis of Residual Fluorescence at the Motor Boundary. [PDF]
Krupa P +7 more
europepmc +1 more source
RAGE Re‐Expressed at Myofibre Level Drives Muscle Wasting in Cancer Conditions
ABSTRACT Background Cancer cachexia (CC) is a highly debilitating syndrome characterized by loss of body and muscle weight affecting most advanced cancer patients. The receptor for advanced glycation end‐products (RAGE) is expressed by several cell types and sustains the inflammatory response in acute and chronic diseases. Total ablation of RAGE (Ager−/
Sara Chiappalupi +10 more
wiley +1 more source
Anlotinib-temozolomide combination achieves durable response in multimodal-resistant primary breast angiosarcoma with skull base metastasis and dural involvement: a case report. [PDF]
Song S, Chen W, Li X, Zhang Y, Wang Y.
europepmc +1 more source
RTA‐408 Enhances Radiosensitivity and Inhibited Tumor Progression via JNK Pathway in Glioblastoma
ABSTRACT Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis owing to its high invasiveness and resistance to therapy. RTA‐408, a synthetic triterpenoid and nuclear factor erythroid 2‐related factor 2 activator, exhibits anti‐inflammatory and anti‐cancer properties; however, its effects on GBM remain unclear. This study investigated the
Hung‐Pei Tsai +6 more
wiley +1 more source
Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data. [PDF]
Wang D +9 more
europepmc +1 more source

